Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Anne Pizard"'
Autor:
Pierpaolo Pellicori, Blerim Mujaj, Stephane Heymans, Fozia Z Ahmed, N. Girerd, Ping Wang, Arantxa González, Hans-Peter Brunner-La-Rocca, Javier Díez, Franco Cosmi, Frank T. Edelmann, Mark R. Hazebroek, João Pedro Ferreira, Joe Cuthbert, Andrew L. Clark, Johannes Petutschnigg, Mamas A. Mamas, Roberto Latini, Job A J Verdonschot, John G.F. Cleland, Beatrice Mariottoni, Patrick Rossignol, Javed Khan, Jan A. Staessen, Burkert Pieske, Faiez Zannad, Anne Pizard, Stéphanie Grojean, Timothy Collier, Philippe Rouet
Publikováno v:
JACC: Heart Failure
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD
JACC: Heart Failure, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC: Heart Failure, Elsevier/American College of Cardiology, 2021, S2213-1779 (20), pp.30705-8. ⟨10.1016/j.jchf.2020.11.010⟩
JACC-Heart Failure, 9(4), 268-277. ELSEVIER SCI LTD
OBJECTIVES This study sought to further understand the mechanisms underlying effect of spironolactone and assessed its impact on multiple plasma protein biomarkers and their respective underlying biologic pathways.BACKGROUND In addition to their bene
Publikováno v:
European Journal of Heart Failure. 19:974-986
The aim of personalized medicine is to offer a tailored approach to each patient in order to provide the most effective therapy, while reducing risks and side effects. The use of mineralocorticoid receptor antagonists (MRAs) has demonstrated major be
Autor:
Jean-Loup Machu, João Pedro Ferreira, Anne-Cecile Huby, Timothy Collier, Naveed Sattar, Javier Díez, Peter S. Sever, Nicolas Girerd, John G.F. Cleland, Faiez Zannad, Anne Pizard, Arantxa González, Patrick Rossignol, Begoña López
Publikováno v:
Heart (British Cardiac Society). 105(4)
BackgroundAn increase in myocardial collagen content may contribute to the development of heart failure; this might be inhibited or reversed by mineralocorticoid receptor antagonists (MRAs). We investigated changes in serum concentrations of the coll
Autor:
C. Richer, M.-P. Vincent, G. Youcef, François Alhenc-Gelas, Anne Pizard, Elise Belaidi, M. Clemessy, L. Fazal, Ludovic Waeckel, G. Zadigue, Michel Ovize
Publikováno v:
Biochemical Pharmacology
Biochemical Pharmacology, Elsevier, 2015, 94 (1), pp.22-29. ⟨10.1016/j.bcp.2015.01.007⟩
Biochemical Pharmacology, 2015, 94 (1), pp.22-29. ⟨10.1016/j.bcp.2015.01.007⟩
Biochemical Pharmacology, Elsevier, 2015, 94 (1), pp.22-29. ⟨10.1016/j.bcp.2015.01.007⟩
Biochemical Pharmacology, 2015, 94 (1), pp.22-29. ⟨10.1016/j.bcp.2015.01.007⟩
International audience; Clinical and experimental studies suggest that pharmacological postconditioning with Cyclosporin A (CsA) reduces infarct size in cardiac ischemia and reperfusion. CsA interacts with Cyclophilin D (CypD) preventing opening of t
Autor:
François Alhenc-Gelas, Christine Richer, Pierre Meneton, Violaine Griol-Charhbili, E Messadi-Laribi, Anne Pizard, Didier Heudes, Marie-Pascale Vincent
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 323:210-216
Angiotensin-converting enzyme inhibitors limit infarct size in animal models of myocardial ischemia reperfusion injury. This effect has been shown to be due to inhibition of bradykinin degradation rather than inhibition of angiotensin II formation. T
Autor:
Patrick G. Burgon, Charles I. Berul, Dan M. Roden, Sabina Kupershmidt, Jonathan G. Seidman, Douglas B. Sawyer, Xinxin Guo, Antonio R. Perez-Atayde, Anne Pizard, Ivan P. Moskowitz, Ferhaan Ahmad, Michael Arad, Mark Walter, Guo H. Li, David Stapleton, Christine E. Seidman, Joachim P. Schmitt, Colin T. Maguire, Vickas V. Patel
Publikováno v:
Circulation. 107:2850-2856
Background— Mutations in the γ 2 subunit ( PRKAG2 ) of AMP-activated protein kinase produce an unusual human cardiomyopathy characterized by ventricular hypertrophy and electrophysiological abnormalities: Wolff-Parkinson-White syndrome (WPW) and p
Autor:
Christiane Pecher, Johan Duchene, Jean-Pierre Girolami, Jean-Loup Bascands, Anne Pizard, Joost P. Schanstra, Christiane Susini, Jean-Pierre Estève
Publikováno v:
Journal of Biological Chemistry. 277:40375-40383
Mitogenic G protein-coupled receptor (GPCR) signaling has been extensively studied. In contrast, little is known about anti-mitogenic GPCR signaling. We show here that anti-mitogenic signaling of a GPCR, the bradykinin B2 receptor, involves a novel d
Autor:
Anne Pizard, Dominique Meng, Laurent Vallar, Rosa-Maria Rodriguez-Guéant, Arnaud Bianchi, C. L’Huillier, Arnaud Olivier, Faiez Zannad, Patrick Lacolley, Gina Youcef
Publikováno v:
Archives of Cardiovascular Diseases Supplements. 6
Mineralocorticoid Receptor Antagonists (MRA) have proven their cardioprotective effects in individuals with chronic heart failure (CHF) by minimizing the cardiovascular damages caused by the excessive aldosterone production observed in those patients
Autor:
Pascal Challande, Patrick Lacolley, Guillaume Galmiche, Carlos Labat, Alexandre Gueret, Antoine Ouvrard-Pascaud, Frederic Jaisser, Stefan Berger, Anne Pizard, Iris Z. Jaffe, Soumaya El Moghrabi
Publikováno v:
Hypertension
Hypertension, 2014, 63 (3), pp.520--526. ⟨10.1161/HYPERTENSIONAHA.113.01967⟩
Hypertension, American Heart Association, 2014, 63 (3), pp.520--526. ⟨10.1161/HYPERTENSIONAHA.113.01967⟩
Hypertension, 2014, 63 (3), pp.520--526. ⟨10.1161/HYPERTENSIONAHA.113.01967⟩
Hypertension, American Heart Association, 2014, 63 (3), pp.520--526. ⟨10.1161/HYPERTENSIONAHA.113.01967⟩
Arterial stiffness is recognized as a risk factor for many cardiovascular diseases. Aldosterone via its binding to and activation of the mineralocorticoid receptors (MRs) is a main regulator of blood pressure by controlling renal sodium reabsorption.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::adb34ec3b8634a447b957bc3f9d01b71
https://hal.science/hal-01460166
https://hal.science/hal-01460166
Publikováno v:
Biological Chemistry
Biological Chemistry, De Gruyter, 2004, 385 (1), pp.49-57. ⟨10.1515/bc.2004.007⟩
Biological Chemistry, 2004, 385 (1), pp.49-57. ⟨10.1515/bc.2004.007⟩
Biological Chemistry, De Gruyter, 2004, 385 (1), pp.49-57. ⟨10.1515/bc.2004.007⟩
Biological Chemistry, 2004, 385 (1), pp.49-57. ⟨10.1515/bc.2004.007⟩
International audience; To investigate the glycosylation of the human bradykinin B2 receptor and the functional significance of this modification, we studied receptors mutated at single or multiple combinations of the three potential N-linked glycosy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e881f1771fc66d4d0c2ad2cc98e92bc9
https://hal.archives-ouvertes.fr/hal-02125641
https://hal.archives-ouvertes.fr/hal-02125641